Eddy S. Yang
Impact in
- Oncology top 1%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
- Cancer Research top 5%
Papers in
- Oncology 74
- PARP inhibition in cancer therapy 39
-
- DNA Repair Mechanisms 32
- Cell death mechanisms and regulation 9
- Epigenetics and DNA Methylation 7
- Co-authors
- Somaira Nowsheen (21 shared papers)Alice N. Weaver (8 shared papers)James A. Bonner (25 shared papers)Deborah Della Manna (6 shared papers)Fen Xia (10 shared papers)Courtney M. Peterson (1 shared paper)Éric Ravussin (1 shared paper)Humaira Jamshed (1 shared paper)
- Journals
- Journal of Clinical Oncology (23 papers)International Journal of Radiation Oncology*Biology*Physics (10 papers)Cancer Research (9 papers)Radiotherapy and Oncology (6 papers)Oncotarget (5 papers)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Eddy S. Yang
162 papers receiving 4.4k citations
Eddy S. Yang's Hit Papers
Peers
Comparison fields: 5 of 125
- Oncology 1.6k
- Cancer Research 527
- Endocrine and Autonomic Systems 224
- Molecular Biology 2.0k
- Otorhinolaryngology 106
Countries citing papers authored by Eddy S. Yang
This map shows the geographic impact of Eddy S. Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eddy S. Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eddy S. Yang more than expected).
Fields of papers citing papers by Eddy S. Yang
This network shows the impact of papers produced by Eddy S. Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eddy S. Yang. The network helps show where Eddy S. Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Eddy S. Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 167 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Early Time-Restricted Feeding Improves 24-Hour Glucose Levels and Affects Markers of the Circadian Clock, Aging, and Autophagy in Humans Hit paper breakdown → | 2019 | 473 |
| 2 | 2013 | 203 | |
| 3 | The intersection between DNA damage response and cell death pathways. | 2012 | 188 |
| 4 | 2003 | 124 | |
| 5 | 2007 | 111 | |
| 6 | 2015 | 108 | |
| 7 | 2008 | 102 | |
| 8 | 2011 | 102 | |
| 9 | 2013 | 96 | |
| 10 | 2012 | 92 | |
| 11 | 2019 | 87 | |
| 12 | 2016 | 84 | |
| 13 | 2017 | 72 | |
| 14 | 2015 | 71 | |
| 15 | 2011 | 70 | |
| 16 | 2011 | 61 | |
| 17 | 2014 | 57 | |
| 18 | 2019 | 57 | |
| 19 | 2012 | 55 | |
| 20 | 2011 | 55 |
About Eddy S. Yang
Eddy S. Yang is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Surgery, having authored 167 papers that have together received 4.5k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (39 papers), DNA Repair Mechanisms (32 papers), Prostate Cancer Treatment and Research (22 papers), Cancer Genomics and Diagnostics (16 papers), Prostate Cancer Diagnosis and Treatment (15 papers), Lung Cancer Treatments and Mutations (12 papers), Cell death mechanisms and regulation (9 papers) and Epigenetics and DNA Methylation (7 papers). The work is most often cited by research in Oncology (1.6k citations), Cancer Research (527 citations), Endocrine and Autonomic Systems (224 citations), Molecular Biology (2.0k citations) and Otorhinolaryngology (106 citations). Eddy S. Yang has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Somaira Nowsheen, Alice N. Weaver, James A. Bonner, Deborah Della Manna, Fen Xia, Courtney M. Peterson, Éric Ravussin, Humaira Jamshed, Robbie A. Beyl and Jennifer Stanley. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Cancer Research, Radiotherapy and Oncology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.